Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;29(3):e13302.
doi: 10.1111/srt.13302.

Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors

Muazzez Cigdem Oba  1 , Ozge Askin  1 , Mehmet Guven Gunver  2 , Gokce Kocaarslan  3 , Deniz Can Alis  3 , Burhan Engin  1
Affiliations

Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors

Muazzez Cigdem Oba et al. Skin Res Technol. 2023 Mar.

Abstract

Background: Hidradenitis suppurativa (HS) is an independent risk factor for the development of subclinical atherosclerosis. Tumour necrosis factor (TNF) inhibitors are effective for the treatment of recalcitrant moderate-to-severe HS. However, the effect of treatment with TNF inhibitors on subclinical atherosclerosis in HS patients has not been previously investigated.

Objectives: In this study, we aimed to assess changes in biochemical parameters (fasting blood glucose and lipid levels) and carotid intima-media thickness (CIMT) values in Hurley stage II and III HS patients undergoing treatment with TNF inhibitors.

Methods: This was a single center prospective study including 30 patients with Hurley stage II and III HS and 30 healthy controls (HCs). Baseline values of biochemical parameters and CIMT were compared to the values recorded after at least 6 months of TNF inhibitor therapy.

Results: CIMT values of the HS patients significantly exceeded those of HCs (for right p = 0.011 and for left p = 0.017). After at least 6 months of TNF inhibitor therapy, there was a statistically significant decrease in fasting blood glucose (p = 0.001), whereas total cholesterol levels significantly increased (p = 0.001). CIMT values also significantly increased (for right p = 0.02 and for left p = 0.01).

Study limitations and conclusions: Small sample size is limitation of the current study. Our study shows that patients with Hurley stage II and III HS undergoing TNF inhibitor therapy are under risk for progression of subclinical atherosclerosis.

Keywords: adalimumab; atherosclerosis; carotid intima-media thickness; hidradenitis suppurativa; infliximab.

PubMed Disclaimer

References

    1. Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366:158‐164. - PubMed
    1. Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec G. Hidradenitis Suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatology Venereol. 2021;35:50‐61. - PubMed
    1. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima‐media thickness: a systematic review and meta‐analysis. Circulation. 2007;115:459‐467. - PubMed
    1. González‐López MA, Hernández JL, Lacalle M, et al. Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol. 2016;75(2):329‐335. - PubMed
    1. Pascual JC, González I, Corona D, et al. Assessment of subclinical atherosclerosis in hidradenitis suppurativa. J Eur Acad Dermatology Venereol J Dermatol. 2017;31(7):1229‐1238. - PubMed

MeSH terms

Substances